Ceribell (CBLL) Research & Development (2023 - 2026)
Ceribell's (CBLL) quarterly Research & Development came in at $22.4 million in Q1 2026, up 427.32% YoY from $4.2 million in Q1 2025, and down 62.05% on a QoQ basis from $59.0 million in Q4 2025.
Ceribell (CBLL) Research & Development (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Research & Development data on file, last reported at $22.4 million in Q1 2026.
- Quarterly Research & Development rose 427.32% year-over-year to $22.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103.8 million (up 74.61% YoY) and the FY2025 annual result came in at $73.1 million, up 48.98% from the prior year.
- Research & Development eased to $22.4 million in Q1 2026, from $59.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $59.0 million in Q4 2025 to a low of $2.3 million in Q3 2023.
- A 4-year average of $17.0 million and a median of $10.8 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development surged 442.63% — and 2025, when it sank 60.21%.
- Tracing CBLL's Research & Development over 4 years: stood at $10.8 million in 2023, then jumped by 264.36% to $39.4 million in 2024, then jumped by 49.73% to $59.0 million in 2025, then slumped by 62.05% to $22.4 million in 2026.
- The last three Research & Development figures came in at $22.4 million (Q1 2026), $59.0 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Ceribell | 933.50 Mn | 804.23 Mn | 25.94 Mn | 24.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.42 Mn |
| Mar 31, 2026 | 22.39 Mn |
| Dec 31, 2025 | 59.00 Mn |
| Sep 30, 2025 | 4.98 Mn |
| Jun 30, 2025 | 17.42 Mn |
| Mar 31, 2025 | 4.25 Mn |
| Dec 31, 2024 | 39.41 Mn |
| Sep 30, 2024 | 12.52 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 10.58 Mn |
| Dec 31, 2023 | 10.82 Mn |
| Sep 30, 2023 | 2.31 Mn |